Assessment of fibrin-fibrinogen degradation products (Accu-Dx) test in bladder cancer patients.

Authors:
  • TKT. Karadeniz
    T. Karadeniz
  • MAM. Ana&Ccedil
    M. Ana&Ccedil
  • SDS. DÖNmezer
    S. DÖNmezer
  • ABA. Besisik
    A. Besisik

Abstract
Measurement of urine fibrin-fibrinogen degradation products has been reported to be a useful marker for bladder malignancies. This is a simple, noninvasive and rapid method in the diagnosis and follow-up of bladder cancer. We performed a prospective study to evaluate the reliability of the Accu-Dx test which detects urinary fibrin and fibrinogen products associated with bladder cancer.